Why the study?
Right ventricular dysfunction worsens prognosis in co-morbid pulmonary hypertension and heart failure with preserved ejection fraction, but the underlying mechanisms driving RV dysfunction remain unclear.
Is diffuse right ventricular fibrosis associated with adverse RV structural and functional remodeling in patients with PH-HFpEF compared to PAH?
Is diffuse right ventricular fibrosis associated with adverse RV structural and functional remodeling in patients with PH-HFpEF compared to PAH?
Diffuse RV fibrosis is present in PH-HFpEF to a similar extent as in PAH and is associated with adverse RV remodeling but not the degree of pulmonary vasculopathy.
Answers are grounded in this paper and cite their sources.
May link diffuse RV fibrosis to adverse remodeling in PH-HFpEF independent of afterload; leaves open its prognostic and therapeutic relevance.
AIMS: While right ventricular (RV) dysfunction is associated with worse prognosis in co-morbid pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF), the mechanisms driving RV dysfunction are unclear. We evaluated the extent and clinical correlates of diffuse RV myocardial fibrosis in PH-HFpEF, as measured by cardiovascular magnetic resonance-derived extracellular volume (ECV). METHODS AND RESULTS: in-plane resolution. RV free wall T1 values were quantified, and ECV was calculated. Participants with PH-HFpEF were older and carried higher rates of hypertension and obstructive sleep apnoea than those with PAH. While RV ECV was similar between PH-HFpEF and PAH (33.1 ± 8.0 vs. 34.0 ± 4.5%; P = 0.57), total pulmonary resistance was lower in PH-HFpEF compared with PAH [PH-HFpEF: 5.68 WU (4.70, 7.66 WU) vs. PAH: 8.59 WU (8.14, 12.57 WU); P = 0.01]. RV ECV in PH-HFpEF was associated with worse indices of RV structure (RV end-diastolic volume: r = 0.67, P = 0.01) and RV function (RV free wall strain: r = 0.59, P = 0.03) but was not associated with RV afterload (total pulmonary resistance: r = 0.08, P = 0.79). Conversely, there was a strong correlation between RV ECV and RV afterload in PAH (r = 0.57, P = 0.04). CONCLUSIONS: Diffuse RV fibrosis, as measured by ECV, is present in PH-HFpEF and is associated with adverse RV structural and functional remodelling but not degree of pulmonary vasculopathy. In PH-HFpEF, diffuse RV fibrosis may occur out of proportion to the degree of RV afterload.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: